Research Purposes Only
This website contains information about research peptides intended strictly for laboratory and scientific research. You must be 18 years or older to enter.
By entering you confirm you are 18+ and agree that all products are for research use only. Not for human consumption.
GLP-1 Receptor Agonist
Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist. Used extensively in metabolic and endocrine research to study insulin secretion, glucagon suppression, and energy homeostasis.
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist with approximately 94% sequence homology to native human GLP-1. It has been structurally modified with a C18 fatty diacid chain attached via a linker to lysine at position 26, enabling albumin binding and extending its half-life significantly compared to native GLP-1. In research settings, semaglutide is used to study GLP-1 receptor signaling, pancreatic beta-cell function, insulin secretion kinetics, glucagon suppression mechanisms, and central nervous system appetite regulation pathways. It is a key research tool in metabolic syndrome and type 2 diabetes research.
Dual GIP/GLP-1 Receptor Agonist
Tirzepatide is a novel dual GIP/GLP-1 receptor agonist. Studied for its combined incretin effects on glucose metabolism, insulin sensitivity, and energy regulation in metabolic research settings.
Nicotinamide Adenine Dinucleotide
NAD+ is a critical coenzyme found in all living cells, central to redox reactions and energy metabolism. Studied extensively for its roles in sirtuin activation, DNA repair, and cellular aging research.
Triple Receptor Agonist (GIP/GLP-1/Glucagon)
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist. Studied for its combined triagonist effects on metabolic regulation, energy expenditure, and glucose homeostasis in laboratory research.
For Research Purposes Only · Not intended for human consumption